Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey D Rothstein

Showing results (31-40 of 215) with videos related to

Pageof 22
Sort By:
Expert Opinion on Investigational Drugs|October 22, 2002
Therapeutic developments in the treatment of amyotrophic lateral sclerosisMandy Jackson, Jerònia Lladó, Jeffrey D Rothstein
Movement Disorders : Official Journal of the Movement Disorder Society|September 13, 2014
Preclinical models: needed in translation? A Pro/Con debateThomas Philips, Jeffrey D Rothstein, Mahmoud A Pouladi
Trends in Neurosciences|June 15, 2014
Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studiesSteve Vucic, Jeffrey D Rothstein, Matthew C Kiernan
Biorxiv : the Preprint Server for Biology|January 3, 2024
Highly variable molecular signatures of TDP-43 loss of function are associated with nuclear pore complex injury in a population study of sporadic ALS patient iPSNsJeffrey D Rothstein, Caroline Warlick, Alyssa N Coyne
Trends in Cell Biology|August 31, 2013
Oligodendroglia: metabolic supporters of axonsBrett M Morrison, Youngjin Lee, Jeffrey D Rothstein
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 7, 2022
Nuclear Pore Dysfunction in NeurodegenerationOlivia Spead, Benjamin L Zaepfel, Jeffrey D Rothstein
Brain Research|April 17, 2009
Tumor necrosis factor-alpha modulates glutamate transport in the CNS and is a critical determinant of outcome from viral encephalomyelitisJessica Carmen, Jeffrey D Rothstein, Douglas A Kerr
Annals of Neurology|March 30, 2004
Altered expression of the glutamate transporter EAAT2b in neurological diseaseNicholas J Maragakis, Margaret Dykes-Hoberg, Jeffrey D Rothstein
Nature Reviews. Neuroscience|May 7, 2016
The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative diseaseAaron R Haeusler, Christopher J Donnelly, Jeffrey D Rothstein
Neuroscience Letters|February 5, 2003
Topiramate protects against motor neuron degeneration in organotypic spinal cord cultures but not in G93A SOD1 transgenic miceNicholas J Maragakis, Mandy Jackson, Raquelli Ganel, et al.
Pageof 22

Showing results (31-40 of 215) with videos related to

Sort By:
Pageof 22
Expert Opinion on Investigational Drugs|October 22, 2002
Therapeutic developments in the treatment of amyotrophic lateral sclerosisMandy Jackson, Jerònia Lladó, Jeffrey D Rothstein
Movement Disorders : Official Journal of the Movement Disorder Society|September 13, 2014
Preclinical models: needed in translation? A Pro/Con debateThomas Philips, Jeffrey D Rothstein, Mahmoud A Pouladi
Trends in Neurosciences|June 15, 2014
Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studiesSteve Vucic, Jeffrey D Rothstein, Matthew C Kiernan
Biorxiv : the Preprint Server for Biology|January 3, 2024
Highly variable molecular signatures of TDP-43 loss of function are associated with nuclear pore complex injury in a population study of sporadic ALS patient iPSNsJeffrey D Rothstein, Caroline Warlick, Alyssa N Coyne
Trends in Cell Biology|August 31, 2013
Oligodendroglia: metabolic supporters of axonsBrett M Morrison, Youngjin Lee, Jeffrey D Rothstein
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 7, 2022
Nuclear Pore Dysfunction in NeurodegenerationOlivia Spead, Benjamin L Zaepfel, Jeffrey D Rothstein
Brain Research|April 17, 2009
Tumor necrosis factor-alpha modulates glutamate transport in the CNS and is a critical determinant of outcome from viral encephalomyelitisJessica Carmen, Jeffrey D Rothstein, Douglas A Kerr
Annals of Neurology|March 30, 2004
Altered expression of the glutamate transporter EAAT2b in neurological diseaseNicholas J Maragakis, Margaret Dykes-Hoberg, Jeffrey D Rothstein
Nature Reviews. Neuroscience|May 7, 2016
The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative diseaseAaron R Haeusler, Christopher J Donnelly, Jeffrey D Rothstein
Neuroscience Letters|February 5, 2003
Topiramate protects against motor neuron degeneration in organotypic spinal cord cultures but not in G93A SOD1 transgenic miceNicholas J Maragakis, Mandy Jackson, Raquelli Ganel, et al.
Pageof 22